News & Articles

The new range is suitable for studies of norovirus protein structure, the research and development of vaccines, and in vitro diagnostic assays

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses

In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development

Newly developed recombinant antigens are derived specifically from 2019-nCoV for use in infectious disease research and assay and vaccine development

Highly scalable kits enable researchers to prepare liquid-stable antigen and antibody conjugates with a wide range of labels including enzymes, fluorochromes, and biotin

New Rubella VLPs promise a reliable source of reagents for consistency in immunoassay development and manufacturing